Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Automotive Regulatory News (CTA)

Share Price Information for Ct Automotive (CTA)

Share Price is delayed by 15 minutes
Get Live Data
31.00    0.50 (1.64%)
Bid:
30.00
Ask:
32.00
Spread: 2.00 (6.667%)
Market Cap: £22.82m
CTA Live PriceLast checked at - London Stock Exchange

Intraday Ct Automotive Share Chart

Director Appointment

16 Feb 2026 07:00

RNS Number : 0406T
CT Automotive Group PLC
16 February 2026
 

16 February 2026

 

CT Automotive Group PLC

("CT Automotive" or the "Group")

 

Director Appointment

 

CT Automotive, a leading designer, developer and supplier of interior components to the global automotive industry, is pleased to announce the appointment of Gary McGrath as an Independent Non-Executive Director, effective immediately.

Gary McGrath is a Chartered Accountant with over 30 years' international finance experience across both listed and private multinational businesses. He has held senior finance leadership roles spanning strategic planning, operational finance, treasury, investor relations and corporate transactions. Most recently, Gary served for ten years as Group Chief Financial Officer of Zotefoams plc, a FTSE-listed world leader in supercritical foams, where he was responsible for the Group's global finance and IT functions and worked closely with the Chief Executive Officer on strategy, capital allocation and shareholder engagement.

Earlier in his career, Gary held a number of senior finance positions within international industrial and manufacturing businesses, working and living in Germany, Belgium and the USA, and gaining broad experience in commercial finance, operational restructuring and business transformation. He brings deep expertise in financial governance, capital markets and supporting growth in international organisations.

Raymond Bench, Chairman of CT Automotive, said:

"I am delighted to welcome Gary McGrath to the Board as an Independent Non-Executive Director. Gary's significant operational and listed company experience will be of great value to the Board, strengthening our strategic planning, governance, and investor relationships."

Regulatory Disclosures

 

Save for the information set out below, there are no further disclosures to be made in accordance with Rule 17, Schedule Two (g) of the AIM Rules for Companies in respect of the appointment of Gary Christopher McGrath, aged 58.

 

Current directorships and partnerships

Past directorships and partnerships (last 5 years)

No current directorships

Zotefoams plc

Zotefoams U.K. Limited

Zotefoams International Ltd

Zotefoams Technology Limited

Zotefoams Inc.

Zotefoams Midwest LLC.

MuCell Extrusion LLC.

Zotefoams Poland Sp.z.o.o.

T-FIT Insulation Solutions India Private Ltd

 

Gary Christopher McGrath does not hold any interest in the ordinary shares of the Company. 

 

Enquiries:

CT Automotive

Raymond Bench, Non-Executive Chairman

Simon Phillips, Chief Executive Officer

 

 

Singer Capital Markets Advisory LLP (Nominated Adviser and Broker)

Alex Bond, James Todd, Samed Ethemi

 

 

Tel: +44 (0)20 7496 3000

 

 

Notes to editors

CT Automotive is engaged in the design, development and manufacture of bespoke automotive interior finishes (for example, dashboard panels and fascia finishes) and kinematic assemblies (for example, air registers, arm rests, deployable cup holders and storage systems), as well as their associated tooling, for the world's leading automotive original equipment manufacturers ("OEMs") and global Tier One manufacturers.

 

The Group is headquartered in the UK with a low cost manufacturing footprint. Key production facilities are located in Shenzhen and Ganzhou, China with additional manufacturing facilities in Mexico and Türkiye and distribution facilities and assembly lines in Europe, Asia and the US. The Company has a low cost design and administrative centre in India.

CT Automotive's operating model enables it to pursue a price leadership strategy, supplying high quality parts to customers at a lower overall landed cost than competitors. This has helped the Group build a high-quality portfolio of OEM customers, both directly and via Tier One suppliers including Forvia and Marelli. End customers include volume manufacturers, such as Nissan, Ford, GM and Volkswagen Audi Group, and premium luxury car brands such as Bentley and Lamborghini. In addition, the Group supplies all our customer base with a range of products for PHEV and BEV platforms and supplies electric car manufacturers, including Rivian and a US based major EV OEM.

The Group currently supplies component part types to over 55 different models for 22 OEMs. Since its formation, the Group has been one of the very few new entrants to the market, which is characterised by high barriers to entry.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAAALFLKKEFA
Date   Source Headline
8th Feb 20137:00 amRNSDirector/PDMR Shareholding
5th Feb 20137:00 amRNSDirector/PDMR Shareholding
28th Jan 20134:01 pmRNSFinal Results
25th Jan 20133:04 pmRNSDoc re. - FORM 8-K
21st Jan 20137:00 amRNSDoc re. Form 8K
14th Jan 20134:44 pmRNSDirector/PDMR Shareholding
14th Jan 20137:00 amRNSDirector/PDMR Shareholding
10th Jan 20137:00 amRNSDirector/PDMR Shareholding
8th Jan 20137:00 amRNSDirector/PDMR Shareholding
4th Jan 20137:00 amRNSDirector/PDMR Shareholding
21st Dec 20127:00 amRNSDirector/PDMR Shareholding
20th Dec 20122:21 pmRNSForm 8-K, Dealer Stats
19th Dec 20127:00 amRNSDirector/PDMR Shareholding
18th Dec 20127:00 amRNSForm 8-K, Board of Directors/Retirment
12th Dec 20124:36 pmRNSDividend Declaration
5th Dec 20127:00 amRNSDirector/PDMR Shareholding
28th Nov 20122:55 pmRNSDirector/PDMR Shareholding
20th Nov 20122:20 pmRNSDoc re: Form 8-K
20th Nov 20127:00 amRNSDirector/PDMR Shareholding
8th Nov 20127:00 amRNSDirector/PDMR Shareholding
7th Nov 20127:00 amRNSDoc re. Executive Officer Retirement Agreement
7th Nov 20127:00 amRNSDirector/PDMR Shareholding
5th Nov 20127:00 amRNSDirector/PDMR Shareholding
2nd Nov 20125:20 pmRNS3rd Quarter Report 10-Q
2nd Nov 20127:00 amRNSDirector/PDMR Shareholding
22nd Oct 20123:05 pmRNS3rd Quarter Results
22nd Oct 20127:00 amRNSDoc re: Form 8-K filing
15th Oct 20127:00 amRNSOfficer Change
8th Oct 20123:16 pmRNSDividend Declaration
3rd Oct 20127:00 amRNSDirector/PDMR Shareholding
1st Oct 20127:00 amRNSDoc re. Form 8-K Filing
21st Sep 20123:29 pmRNSDoc re. Form 8-K Filing
18th Sep 20127:00 amRNS8-K Filed
6th Sep 20127:00 amRNSDirector/PDMR Shareholding
29th Aug 20127:00 amRNSDoc re: Form 8-K Filing
22nd Aug 20127:00 amRNSDirector/PDMR Shareholding
21st Aug 20127:00 amRNSDoc re. Form 8-K Filed
21st Aug 20127:00 amRNSDoc re Form 8-K Filing
13th Aug 20127:00 amRNSDoc re: Form 8-K Filing
7th Aug 20127:00 amRNSDoc re. Half Yearly Report
3rd Aug 20127:00 amRNSDirector/PDMR Shareholding
2nd Aug 20127:00 amRNSDirector/PDMR Shareholding
30th Jul 20127:00 amRNSDoc re Form 8-K Filing
25th Jul 20122:39 pmRNSHalf Yearly Report
4th Jul 20127:00 amRNSDirector/PDMR Shareholding
26th Jun 20127:00 amRNSDoc re. Form 8-K filed
13th Jun 20126:06 pmRNSDividend Declaration
6th Jun 20127:00 amRNSDirector/PDMR Shareholding
9th May 20127:00 amRNSDirector/PDMR Shareholding
8th May 20127:00 amRNS1st Quarter Report on Form 10-Q (excluding RNA)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.